Riskpilot← Back to searchSign inGet full accessAtleva OrtopediCenter AB
ABActiveOrg 5568796394Entreprenörsstråket 6Medical specialists activities · NACE 8622Est. 20125-9 employees
Revenue 2024
SEK 7,2M
+1382% vs 2023
EBITDA margin
-28.1%
-112% vs 2023
Equity ratio
5.1%
Financial strength
Net profit 2024
SEK -6K
| Revenue | SEK 7,2M | +1382% |
| EBITDA | SEK -2M | -112% |
| Net profit | SEK -6K | — |
| Total assets | SEK 3,7M | +326% |
| Equity | SEK 187K | -3% |
| Employees | — | — |
Legal name
Atleva OrtopediCenter AB
Org number
5568796394
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
3 januari 2012
Share capital
SEK 55 000
Employees
5-9
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva sjukvård inom ortopedi samt därmed förenlig verksamhet.
Address
Entreprenörsstråket 6
Email
jorgen.emanuelsson@atleva.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 284 | 815 | 790 | 488 | 7 231 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 623 | −1 285 | −4 980 | −959 | −2 034 |
| Depreciation & amort. | −46 | −229 | −659 | −26 | −12 |
| EBIT | −1 669 | −1 514 | −5 639 | −985 | −2 046 |
| Net financials | −2 | −1 | — | — | −1 |
| Profit before tax | 65 | −165 | 157 | 0 | −6 |
| Tax | −0 | 33 | −33 | −0 | −0 |
| Net profit | 65 | −132 | 124 | 0 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 052 | 964 | 2 557 | 863 | 3 675 |
| Equity | 115 | 63 | 187 | 192 | 187 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 936 | 901 | 2 370 | 671 | 3 488 |
| Total debt | 936 | 901 | 2 370 | 671 | 3 488 |
EBITDA margin
-28.1%
This company
15.8%
Market median
-278% vs market
20202024
Equity ratio
5.1%
This company
38.2%
Market median
-87% vs market
20202024
Return on equity
-3.2%
This company
18.4%
Market median
-117% vs market
20202024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20202024
Asset turnover
1.97×
This company
1.12×
Market median
+76% vs market
20202024
Debt / equity
18.65×
This company
0.62×
Market median
-2908% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CP Chief Auditor | Chief Auditor | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Chairman | 2022 | |
| Former (1) | ||
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 91% | 91% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Atnotera ABAtleva Specialistvård Intressenter ABAtleva Specialistvård AB
Atleva OrtopediCenter AB (this company)Board members of Atleva OrtopediCenter AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Patrik Resebo | Chief Auditor | 0 companies |
| Kjell Jörgen Emanuelsson | Board of Directors | 0 companies |
| Lars Ola Collin | Deputy Board Member | 0 companies |
| Ulrika Eleonora Olbe | Chairman | 0 companies |
| Astrid Camilla Sjögren | Chairman | 0 companies |